Testing JMKX000189 for Chemo-Related Nerve Pain
Part of Brain & nervous system, Pain clinical trials.
This trial tests a new drug called JMKX000189 to see if it can safely reduce nerve pain and tingling caused by cancer chemotherapy. If you've completed cancer treatment and are struggling with these symptoms, this study may help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have been diagnosed with cancer (confirmed by biopsy or cell sample) and received chemotherapy
- You are experiencing nerve pain, tingling, or numbness as a result of that chemotherapy (called CIPN)
- Your overall health status is good enough to participate (ECOG score of 2 or less, meaning you can do light activity)
- You have a life expectancy of at least 3 months
- Your organs (heart, kidneys, liver) are working adequately
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new gel (VMD-3866) applied to the skin to treat moderate nerve pain, numbness, or tingling caused by previous chemotherapy. It aims to see if the gel can safely reduce pain for people whose symptoms have been stable for at least 8 weeks.
This study is testing an experimental drug (AK135) to see if it can reduce nerve pain and numbness caused by chemotherapy in people with cancer. It might help if you have ongoing nerve symptoms after finishing certain chemo treatments.
This trial tests whether acupuncture and compression therapy can prevent nerve damage caused by taxane chemotherapy in early-stage breast cancer. It aims to reduce numbness, tingling, or pain in the hands and feet.
This trial tests whether spinal cord stimulation can reduce pain and improve quality of life in people with long-lasting nerve pain from chemotherapy (CIPN). You must already have tried at least two nerve-pain medicines and still have significant pain, and you must have had a successful spinal cord stimulator test before joining.
This study looks for small molecules in the blood that might predict nerve damage caused by certain chemotherapies. If you have colorectal or lung cancer and are starting a specific chemo plan, this trial could help researchers understand why some people get nerve problems and others don't.
This trial tests if adding electroacupuncture, a gentle type of acupuncture using mild electric pulses, can help relieve nerve pain, tingling, or numbness caused by chemotherapy in people with cancer.
Hear when a new CIPN - Chemotherapy-Induced Peripheral Neuropathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.